Patricio G. Contesse
Analyst · Scotiabank
Good morning, and thank you for joining the SQM Fourth Quarter Earnings Conference Call. I will start with a brief introduction before we open up the lines for questions. On Tuesday evening, we posted our results for 2013. Earnings for this period reached $466.1 million, a decrease from $649.2 million reported for the same period last year. Revenues totaled $2.2 billion, a decrease of 9.3% compared to the $2.4 billion reported during 2012. These lower results of 2013 reflect the difficult conditions which surround our main business lines for the year. Generally speaking, increase volumes in the potassium chloride business line help us to partially offset lower prices seen during the year. Prices fell above 15% year-on-year. Our margins, as anticipated, were impact. Our SQM business line did very [ph] well during 2013. Volume increased, and even though prices are not directly related to the potassium chloride prices, prices fell just in light of potassium chloride market condition. We look forward to higher volumes in both business lines during 2012 -- excuse me, 2014. We are aware that there has been a lot of interest surrounding the iodine and lithium market in recent months. Following the positive trend during the past several years, we saw demand growth in both the [indiscernible] lithium and world [ph] iodine market during 2013. However, a new supply of iodine in excess of market growth has been added by existing competitors. This ultimately had a negative impact on our sales volume in this business lines during 2013 when compared to 2012. Continuing with iodine, we did see lower prices as anticipated during the first months of 2014. We will likely to continue to face challenges to assume the uncertainty related to the production and sales volume of our competitors in this market throughout the year. We are confident in our long-term position in the iodine market as the largest producer with significant cost advantages. And although volumes maybe lower in 2014, we will protect our market share in the long term. In the lithium market, we expect market growth between 8% to 10% in 2014. We continue to be the world's largest producer of lower cost produce -- but we'll assess new supplies and its potential impact on the market in the short term. In industrial chemical, we saw sales volume and revenues significantly lower than in 2012. This was in line with our expectations as solar salt sales reached approximately 70,000 metric tons during 2013 compared to 170,000 metric tons in 2012. On a positive note, we see increased interest in the market and are currently negotiating contract for 2015 and 2016. We remain confident in the long-term prospect in the solar salt market. Our capital expenditure in 2013 reached $331.7 million, which were below our estimate of $400 million. In 2014, as it was anticipated, our CapEx will be close to $150 million. During 2014, we will benefit from recent investments, specifically investment in May [ph], to increase production of the potassium-based fertilizer from the Salar De Atacama. We will keep our [indiscernible] iodine and lithium in the pipeline and we will move forward with them after careful review of market condition and approval from the board. I will close by saying that 2014 will be transitional year for SQM. As I mentioned in the press release, we are well positioned to move quickly to meet any changes in market demand and market dynamics in all of the main business in which we serve. Rest assured we will act on what we believe to be in the best interest for the long term of the company and remain focus on maximizing margins and shareholders' value. Any strategy and decision [ph] will reflect this goal. Thank you.